Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Infant Bacterial Therapeutics AB (publ)
IBT-BCurrent price
34.3 SEK
-2.52 SEK (-6.79%)
Last closed
36.4 SEK
Company
www.ibtherapeutics.com
ISIN
SE0008015259
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
480 441 120 SEK
Yield for 12 month
-62.06 %
1Y
3Y
5Y
10Y
15Y
IBT-B
Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent serious neonatal diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, which is in Phase III clinical studies `to prevent necrotizing enterocolitis, as well as to improve feeding tolerance in premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe birth abnormality in infants. In addition, its drug candidates include IBP-1118 to prevent retinopathy of prematurity that causes blindness in premature babies; and IBP-1122, indicated to eliminate vancomycin resistant enterococci that cause antibiotic resistant hospital infections. The company was incorporated in 2011 and is based in Stockholm, Sweden. Address: Bryggargatan 10, Stockholm, Sweden, 111 21
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3 295.31 SEKP/E ratio
–Dividend Yield
–Current Year
+78 011 SEK
Last Year
+12 160 SEK
Current Quarter
–
Last Quarter
+5 064 SEK
Current Year
+78 011 SEK
Last Year
+12 160 SEK
Current Quarter
–
Last Quarter
+5 064 SEK
Key Figures IBT-B
1 year
3 years
5 years
10 years
EBITDA
-135 563 925 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-31.25 %
PEG Ratio
–
Return On Equity TTM
-54.97 %
Wall Street Target Price
3 295.31 SEK
Revenue TTM
69 909 SEK
Book Value
17.8 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-61.5 %
Dividend Yield
–
Gross Profit TTM
12 158 SEK
Earnings per share
-10.75 SEK
Diluted Eps TTM
-10.75 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-61.7 %
Profit Margin
–
Dividend Analytics IBT-B
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IBT-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation IBT-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
6872.366
Enterprise Value EBITDA
-3.9083
Price Book MRQ
2.0035
Financials IBT-B
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IBT-B
For 52 weeks
21.99 SEK
136.78 SEK
50 Day MA
36.06 SEK
Shares Short Prior Month
–
200 Day MA
80.66 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart